PURPOSE: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effects in chronically infarcted hearts. The purpose of this study was to test whether prevention of the deterioration of mechanical function by ACE inhibitors is related to beneficial effects on high-energy phosphate metabolism that is deranged in heart failure. METHODS: Twelve-week old rats were randomly assigned to ligation of the left coronary artery [mycardial infarction (MI)] or sham operation (Sham) and to the ACE inhibitor quinapril (+Q) (6 mg/kg/day per gavage) or placebo treatment. Eight weeks later, cardiac function was measured in the isolated heart by a left ventricular balloon (pressure-volume curves), and energy metabolism of residua...
Objectives : We investigated the effects of a novel ultrapotent poly(adenosine diphosphate-ribose) p...
Heart failure after myocardial infarction (MI) is associated with endothelial dysfunction. There is ...
We evaluated the effects of a new angiotensin-converting enzyme (ACE) inhibitor (idrapril) in terms ...
PURPOSE: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effect...
Purpose: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effect...
We tested whether angiotensin-converting enzyme (ACE) inhibitor therapy with quinapril prevents the ...
Chronic treatment with β-receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in hear...
OBJECTIVES: This study was designed to analyze the effects of acute angiotensin-converting enzyme (A...
Study objective - The aim was to compare the effects of two novel angiotensin converting enzyme (ACE...
Background: The antihypertensive and renoprotective effects of ACE inhibitor (ACEi) therapy are enha...
It has been shown that converting enzyme inhibitors (CEI) attenuate ventricular dilatation and hyper...
OBJECTIVE: In heart failure, cardiac energy metabolism is compromised. The failing myocardium is cha...
OBJECTIVES: We tested the hypothesis that long-term beta-blocker treatment with bisoprolol prevents ...
n genetic and acquired hypertension, a structural remodeling of the nonmyocyte compartment of myocar...
1. Cardiac angiotensin-converting enzyme (ACE) is localized in high concentration in cardiac valves,...
Objectives : We investigated the effects of a novel ultrapotent poly(adenosine diphosphate-ribose) p...
Heart failure after myocardial infarction (MI) is associated with endothelial dysfunction. There is ...
We evaluated the effects of a new angiotensin-converting enzyme (ACE) inhibitor (idrapril) in terms ...
PURPOSE: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effect...
Purpose: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effect...
We tested whether angiotensin-converting enzyme (ACE) inhibitor therapy with quinapril prevents the ...
Chronic treatment with β-receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in hear...
OBJECTIVES: This study was designed to analyze the effects of acute angiotensin-converting enzyme (A...
Study objective - The aim was to compare the effects of two novel angiotensin converting enzyme (ACE...
Background: The antihypertensive and renoprotective effects of ACE inhibitor (ACEi) therapy are enha...
It has been shown that converting enzyme inhibitors (CEI) attenuate ventricular dilatation and hyper...
OBJECTIVE: In heart failure, cardiac energy metabolism is compromised. The failing myocardium is cha...
OBJECTIVES: We tested the hypothesis that long-term beta-blocker treatment with bisoprolol prevents ...
n genetic and acquired hypertension, a structural remodeling of the nonmyocyte compartment of myocar...
1. Cardiac angiotensin-converting enzyme (ACE) is localized in high concentration in cardiac valves,...
Objectives : We investigated the effects of a novel ultrapotent poly(adenosine diphosphate-ribose) p...
Heart failure after myocardial infarction (MI) is associated with endothelial dysfunction. There is ...
We evaluated the effects of a new angiotensin-converting enzyme (ACE) inhibitor (idrapril) in terms ...